Personal Genome Diagnostics, Human Longevity Ink Oncology Genomics Deal | GenomeWeb

NEW YORK (GenomeWeb) – Personal Genome Diagnostics and Human Longevity today announced they have signed a collaborative agreement to provide genomic sequencing services to each other.

Human Longevity will have access to PGDx cancer genome analysis panels including CancerSelect, PlasmaSelectCancerXome, METDetec, and CancerComplete. It has also licensed the PGDx Enterprise Solution platform, which enables laboratories to conduct their own advanced cancer genomic testing using next-generation sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.